Effect of dapagliflozin on outcomes in women and men with heart failure with reduced ejection fraction in the DAPA-HF trial

被引：0
|
作者：
Butt, J. H. [1 ]
Kober, L. [1 ]
Docherty, K. F. [2 ]
Inzucchi, S. E. [3 ]
Kosiborod, M. N. [4 ]
Langkilde, A. M. [5 ]
Martinez, F. [6 ]
Bengtsson, O. [5 ]
Ponikowski, P. [7 ]
Demets, D. L. [8 ]
Sjostrand, M. [5 ]
Sabatine, M. S. [9 ]
Solomon, S. D. [9 ]
Jhund, P. S. [2 ]
Mcmurray, J. John [2 ]
机构：
[1] Univ Copenhagen, Dept Cardiol, Copenhagen, Denmark
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Yale Univ, Sch Med, Dept Endocrinol, New Haven, CT USA
[4] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[5] AstraZeneca, Gothenburg, Sweden
[6] Univ Cordoba, Cordoba, Argentina
[7] Wroclaw Med Univ, Warsaw, Poland
[8] Univ Wisconsin, Madison, WI 53706 USA
[9] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
90
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [21] Effects of Dapagliflozin on Physical and Social Activity Limitations in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of DAPA-HF
    Docherty, Kieran
    Kosiborod, Mikhail N.
    Inzucchi, Silvio E.
    Kober, Lars
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjastrand, Mikaela
    Solomon, Scott
    Jhund, Pardeep S.
    McMurray, John J.
    CIRCULATION, 2020, 142
  • [22] High-Sensitivity Cardiac Troponin and the Efficacy of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial
    Berg, David D.
    Sabatine, Marc S.
    Sattar, Naveed
    Jarolim, Petr
    Welsh, Paul
    Jhund, Pardeep S.
    Anand, Inder
    De Boer, Rudolf A.
    Kosiborod, Mikhail
    O'Meara, Eileen
    Hammarstedt, Ann
    CIRCULATION, 2021, 144
  • [23] Outcomes related to IGFBP-7 in patients with heart failure and reduced ejection fraction and effects of dapagliflozin: findings from DAPA-HF
    Adamson, C.
    Welsh, P.
    Morrow, D. A.
    Docherty, K. F.
    Hammarstedt, A.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Solomon, S. D.
    Sattar, N.
    Jhund, P. S.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 913 - 913
  • [24] Relationship between endothelin-1, heart failure with reduced ejection fraction and dapagliflozin: findings from DAPA-HF
    Yeoh, S. E.
    Docherty, K. F.
    Jhund, P. S.
    Hammarstedt, A.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Solomon, S. D.
    Sattar, N.
    Welsh, P.
    Sabatine, M. S.
    Morrow, D. A.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 833 - 833
  • [25] Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF (vol 142, 1040, 2020)
    Jackson
    CIRCULATION, 2020, 142 (20)
  • [26] The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fraction
    Verma, Subodh
    CARDIOVASCULAR RESEARCH, 2020, 116 (01) : E8 - E10
  • [27] Effect of Dapagliflozin According to Duration of Heart Failure: An Analysis of the DAPA-HF Trial
    Yeoh, Su E.
    Docherty, Kieran
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail
    Langkilde, Anna Maria
    Martinez, Feilpe A.
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjastrand, Mikaela
    Solomon, Scott
    Jhund, Pardeep S.
    McMurray, John J.
    CIRCULATION, 2020, 142
  • [28] Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial
    Berg, David D.
    Docherty, Kieran F.
    Sattar, Naveed
    Jarolim, Petr
    Welsh, Paul
    Jhund, Pardeep S.
    Anand, Inder S.
    Chopra, Vijay
    de Boer, Rudolf A.
    Kosiborod, Mikhail N.
    Nicolau, Jose C.
    O'Meara, Eileen
    Schou, Morten
    Hammarstedt, Ann
    Langkilde, Anna-Maria
    Lindholm, Daniel
    Sjostrand, Mikaela
    McMurray, John J. V.
    Sabatine, Marc S.
    Morrow, David A.
    CIRCULATION, 2022, 145 (03) : 158 - 169
  • [29] Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF
    Inzucchi, Silvio E.
    Docherty, Kieran F.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Solomon, Scott D.
    Verma, Subodh
    Belohlavek, Jan
    Boehm, Michael
    Chiang, Chern-En
    de Boer, Rudolf A.
    Diez, Mirta
    Dukat, Andre
    Ljungman, Charlotta E. A.
    Bengtsson, Olof
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Jhund, Pardeep S.
    McMurray, John J. V.
    DIABETES CARE, 2021, 44 (02) : 586 - 594
  • [30] Efficacy and safety of dapagliflozin in black, compared to white, patients with heart failure with reduced ejection fraction: Results from DAPA-HF
    Docherty, K. F.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Bengtsson, O.
    Ponikowski, P.
    Sabatine, M. S.
    Sjostrand, M.
    Solomon, S. D.
    Langkilde, A. M.
    Jhund, P. S.
    Mcmurray, J. J. V. John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 56 - 56
12345